Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors
NCT01999738
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
93
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Non Small Cell Lung Carcinoma
Interventions
DRUG:
EC1456 and EC20
Sponsor
Endocyte